Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Artocoron
2. Azunaftil
3. Di Actane
4. Di-actane
5. Dusodril
6. Gvatran
7. Ls 121
8. Ls-121
9. Ls121
10. Nafronyl
11. Nafronyl Oxalate
12. Nafronyloxalate
13. Nafti Puren
14. Nafti Ratiopharm
15. Nafti Von Ct
16. Nafti-puren
17. Nafti-ratiopharm
18. Naftidrofuryl
19. Naftifurin Oxalate
20. Naftilong
21. Naftilux
22. Naftiratiopharm
23. Oxalate, Nafronyl
24. Oxalate, Naftifurin
25. Praxilne
1. Iridus
2. Ls 121
3. Diethyl-[2-[2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoyl]oxyethyl]azanium;2-hydroxy-2-oxoacetate
4. 5adb8d9388
5. Naphtidrofuryl Oxalate
6. Einecs 221-703-0
7. Nsc 225233
8. Unii-5adb8d9388
9. 2-(diethylamino)ethyl Tetrahydro-alpha-(1-naphthylmethyl)-2-furanpropionate Oxalate (1:1)
10. 2-furanpropanoic Acid, Tetrahydro-alpha-(1-naphthalenylmethyl)-, 2-(diethylamino)ethyl Ester, Ethanedioate (1:1)
11. 2-furanpropionic Acid, Tetrahydro-alpha-(1-naphthylmethyl)-, 2-(diethylamino)ethyl Ester, Oxalate (1:1)
12. Diethyl(2-(2-(1-naphthylmethyl)-3-(tetrahydro-2-furyl)propionyloxy)ethyl)ammonium Hydrogen Oxalate
| Molecular Weight | 473.6 g/mol |
|---|---|
| Molecular Formula | C26H35NO7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 11 |
| Exact Mass | 473.24135246 g/mol |
| Monoisotopic Mass | 473.24135246 g/mol |
| Topological Polar Surface Area | 117 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 543 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
ABOUT THIS PAGE
A Gevatran manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gevatran, including repackagers and relabelers. The FDA regulates Gevatran manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gevatran API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Gevatran supplier is an individual or a company that provides Gevatran active pharmaceutical ingredient (API) or Gevatran finished formulations upon request. The Gevatran suppliers may include Gevatran API manufacturers, exporters, distributors and traders.
click here to find a list of Gevatran suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gevatran CEP of the European Pharmacopoeia monograph is often referred to as a Gevatran Certificate of Suitability (COS). The purpose of a Gevatran CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Gevatran EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Gevatran to their clients by showing that a Gevatran CEP has been issued for it. The manufacturer submits a Gevatran CEP (COS) as part of the market authorization procedure, and it takes on the role of a Gevatran CEP holder for the record. Additionally, the data presented in the Gevatran CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Gevatran DMF.
A Gevatran CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Gevatran CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Gevatran suppliers with CEP (COS) on PharmaCompass.
Gevatran Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gevatran GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gevatran GMP manufacturer or Gevatran GMP API supplier for your needs.
A Gevatran CoA (Certificate of Analysis) is a formal document that attests to Gevatran's compliance with Gevatran specifications and serves as a tool for batch-level quality control.
Gevatran CoA mostly includes findings from lab analyses of a specific batch. For each Gevatran CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gevatran may be tested according to a variety of international standards, such as European Pharmacopoeia (Gevatran EP), Gevatran JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gevatran USP).
LOOKING FOR A SUPPLIER?
